학술논문

Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel
Document Type
Article
Source
In: Annals of Hematology. (Annals of Hematology, June 2024, 103(6):1909-1917)
Subject
Language
English
ISSN
14320584
09395555